Dr. Alborz Jooya is a Radiation Oncologist at the Arthur J.E. Child Comprehensive Cancer Centre and an Assistant Professor in the Department of Oncology at the Cumming School of Medicine, University of Calgary. He is also a Member of the Arnie Charbonneau Cancer Institute. Dr. Jooya completed his MD.CM and MSc at McGill University, his Radiation Oncology residency (FRCPC) at The Ottawa Hospital, University of Ottawa, and a Magnetic Resonance Linac (MRL) Fellowship at Princess Margaret Hospital, Toronto. He holds the Diplomate of the American Board of Radiology (DABR). Dr. Jooya is engaged in cutting-edge research on MR-LINAC technology, with a particular emphasis on stereotactic radiotherapy for breast, gastrointestinal (GI), genitourinary (GU), and oligometastatic cancers. His research integrates clinical oncology with MRL-based treatments and is committed to advancing innovative cancer treatment strategies.
Jooya, Alborz
Radiation Oncology
Assistant Professor
MD.CM, MSc, FRCPC, DABR
Biography
Area of Focus
MR-LINAC based stereotactic radiotherapy for breast, gastrointestinal (GI), genitourinary (GU), and oligometastatic cancers.
Summary of Research
Dr. Jooya’s research focuses on the use of ablative radiotherapy for various primary and metastatic malignancies using stereotactic body radiotherapy (SBRT) with an MR-Linac System. This includes feasibility studies of ablative treatments for GI cancers such as liver tumors, and GU tumors of the prostate or kidney. His research also encompasses practice-based training strategies to transition from radiation oncologist to therapist-driven adaptive SBRT for the MR-Linac System. Additionally, Dr. Jooya is addressing gaps in health-related Quality of Life (HRQOL) outcomes in patients with oligometastatic or upper gastrointestinal malignancies treated on MRL systems, through prospective QOL data collection and analysis.
Area Of Focus
MR-LINAC based stereotactic radiotherapy for breast, gastrointestinal (GI), genitourinary (GU), and oligometastatic cancers.
Summary Of Research
Dr. Jooya’s research focuses on the use of ablative radiotherapy for various primary and metastatic malignancies using stereotactic body radiotherapy (SBRT) with an MR-Linac System. This includes feasibility studies of ablative treatments for GI cancers such as liver tumors, and GU tumors of the prostate or kidney. His research also encompasses practice-based training strategies to transition from radiation oncologist to therapist-driven adaptive SBRT for the MR-Linac System. Additionally, Dr. Jooya is addressing gaps in health-related Quality of Life (HRQOL) outcomes in patients with oligometastatic or upper gastrointestinal malignancies treated on MRL systems, through prospective QOL data collection and analysis.